Martens, Pieter http://orcid.org/0000-0002-6036-2113
Tang, W. H. Wilson
Funding for this research was provided by:
Belgian American Educational Foundation
Article History
Accepted: 8 May 2023
First Online: 25 May 2023
Declarations
:
: Dr. Martens has received consultancy fees from AstraZeneca, Abbott, Bayer, Boehringer-Ingelheim, Daiichi Sankyo, Novartis, Novo Nordisk and Vifor pharma. Dr. Tang is a consultant for Sequana Medical, Cardiol Therapeutics, Genomics plc, Zehna Therapeutics, Renovacor, WhiteSwell, Boston Scientific, Kiniksa, and has received honorarium from Springer Nature and American Board of Internal Medicine.
: This article does not contain any studies with human or animal subjects performed by any of the authors.